(4aS,8aS,9S)-3-(benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-4H,4aH,5H,8H,9H-naphtho(2,3-d)(1,2)oxazole-4,5-dione

This compound is a synthetic intermediate used in the platform-based synthesis of novel tetracycline antibiotics. It features a key chiral scaffold with protective silyl and benzyl ether groups, enabling further chemical modifications for antibiotic development.